Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors.

Development of antivirals for dengue is now based on rational approach targeting the enzymes involved in its life cycle. Among the targets available for inhibition of dengue virus, non-structural protein NS2B-NS3 protease is considered as a promising target for the development of anti-dengue agents. In the current study we have synthesized a series of 4-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)benzene-1-sulphonamide derivatives and screened for DENV2 protease activity. Compounds 16 and 19 showed IC50 of DENV2 Protease activity with 48.2 and 121.9μM respectively. Molecular docking and molecular dynamic simulation studies were carried out to know the binding mode responsible for the activity. MD simulations revealed that, NS2B/NS3 protease was more stable when it binds with the active compound. Structure optimization of the lead compounds 16 and 19 and their co-crystallization studies are underway.

[1]  G Narahari Sastry,et al.  Virtual high throughput screening in new lead identification. , 2011, Combinatorial chemistry & high throughput screening.

[2]  E. Holmes,et al.  The causes and consequences of genetic variation in dengue virus. , 2000, Trends in microbiology.

[3]  E. Henchal,et al.  The dengue viruses , 1990, Clinical Microbiology Reviews.

[4]  H. Walter,et al.  Tipranavir analogous 3-sulfonylanilidotetronic acids: new synthesis and structure-dependent anti-HIV activity , 2008 .

[5]  George M. Sheldrick,et al.  SADABS, Program for Empirical Absorption Correction of Area Detector Data , 1996 .

[6]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[7]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[8]  Christoph Nitsche,et al.  Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. , 2011, Bioorganic & medicinal chemistry.

[9]  Zheng Yin,et al.  Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus , 2006, Nature Structural &Molecular Biology.

[10]  K. Matsuo,et al.  A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts , 2015, PloS one.

[11]  Louis J. Farrugia,et al.  WinGX and ORTEP for Windows: an update , 2012 .

[12]  R. Padmanabhan,et al.  Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro. , 2013, Antiviral research.

[13]  Suzanne M. Tomlinson,et al.  Anthracene-based inhibitors of dengue virus NS2B-NS3 protease. , 2011, Antiviral research.

[14]  E. Åkerblom,et al.  Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' Region. , 2014, ACS medicinal chemistry letters.

[15]  L. M. Lima,et al.  Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. , 2002, Bioorganic & medicinal chemistry.

[16]  R. Liskamp,et al.  Increased stability of peptidesulfonamide peptidomimetics towards protease catalyzed degradation. , 1999, Bioorganic & medicinal chemistry.

[17]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[18]  R. Bartenschlager,et al.  Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. , 2011, Bioorganic & medicinal chemistry.

[19]  I. Kurnaz,et al.  Synthesis and antimycobacterial activity of some phthalimide derivatives. , 2012, Bioorganic & medicinal chemistry.

[20]  D. Gubler,et al.  Dengue and dengue haemorrhagic fever , 1998, The Lancet.

[21]  P. Gething,et al.  Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus , 2012, PLoS neglected tropical diseases.

[22]  S. Wann,et al.  Characteristics of a dengue hemorrhagic fever outbreak in 2001 in Kaohsiung. , 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[23]  B. Luna,et al.  Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. , 2007, Clinical therapeutics.

[24]  G. Otting,et al.  Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts. , 2011, Journal of the American Chemical Society.

[25]  G. Lushington,et al.  Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases. , 2013, Bioorganic & medicinal chemistry.

[26]  Raymond E. Davis,et al.  Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .

[27]  Tan Siew Kiat,et al.  Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. , 2006, Bioorganic & medicinal chemistry letters.

[28]  F. Guirakhoo,et al.  Traditional and novel approaches to flavivirus vaccines. , 2003, International journal for parasitology.

[29]  D. Gubler,et al.  Dengue/dengue hemorrhagic fever: the emergence of a global health problem. , 1995, Emerging infectious diseases.

[30]  G. Lushington,et al.  Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives. , 2012, Bioorganic & medicinal chemistry.

[31]  P. Shi,et al.  Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation , 2011, Journal of Virology.

[32]  C. Steuer,et al.  Optimization of Assay Conditions fo r Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents , 2009, Journal of biomolecular screening.

[33]  P A Kollman,et al.  An analysis of the interactions between the Sem-5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis. , 2001, Journal of the American Chemical Society.